Phosphoenolpyruvate carboxylase variant and method for producing 5à ¢â,¬â,,¢-inosinic acid using same

US12410455B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12410455-B2
Application numberUS-202318879948-A
CountryUS
Kind codeB2
Filing dateAug 31, 2023
Priority dateApr 6, 2023
Publication dateSep 9, 2025
Grant dateSep 9, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a novel phosphoenolpyruvate carboxylase variant and a method of producing 5′-inosinic acid using the same. The phosphoenolpyruvate carboxylase variant is obtained by substituting one or more amino acids in the amino acid sequence constituting phosphoenolpyruvate carboxylase to change the activity of the protein, and a recombinant microorganism comprising the phosphoenolpyruvate carboxylase variant is capable of efficiently producing 5′-inosinic acid.

First claim

Opening claim text (preview).

The invention claimed is: 1. A phosphoenolpyruvate carboxylase variant in which one or more of the amino acids at positions 472 and 673 in the amino acid sequence of SEQ ID NO: 4 is/are substituted with other amino acid(s). 2. The phosphoenolpyruvate carboxylase variant of claim 1 , which consists of the amino acid sequence of SEQ ID NO: 2 in which proline at position 472 in the amino acid sequence of SEQ ID NO: 4 is substituted with serine and glycine at position 673 is substituted with aspartic acid. 3. A polynucleotide encoding the variant of claim 1 . 4. A transformant host cell comprising the variant of claim 1 or the polynucleotide of claim 3 . 5. The transformant host cell of claim 4 , which is a Corynebacterium sp. microorganism. 6. The transformant host cell of claim 4 , which has ability to produce 5′-inosinic acid. 7. A method for producing 5′-inosinic acid, comprising steps of: culturing the transformant host cell of claim 4 in a medium; and recovering 5′-inosinic acid from the transformant host cell or the medium in which the transformant host cell has been cultured. 8. A transformant host cell comprising the polynucleotide of claim 3 .

Assignees

Inventors

Classifications

  • having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides · CPC title

  • Phosphoenolpyruvate carboxylase (4.1.1.31) · CPC title

  • Lyases (4.) · CPC title

  • Corynebacterium · CPC title

  • Bacteria; Culture media therefor · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12410455B2 cover?
The present invention relates to a novel phosphoenolpyruvate carboxylase variant and a method of producing 5′-inosinic acid using the same. The phosphoenolpyruvate carboxylase variant is obtained by substituting one or more amino acids in the amino acid sequence constituting phosphoenolpyruvate carboxylase to change the activity of the protein, and a recombinant microorganism comprising the pho…
Who is the assignee on this patent?
Daesang Corp
What technology area does this patent fall under?
Primary CPC classification C12P19/32. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).